Skip to main content
SpringerLink
Log in

18F-FDG PET/CT for Bone and Soft Tissue Biopsy

  • Chapter
  • First Online:
Oncological PET/CT with Histological Confirmation

  • 710 Accesses

Abstract

In the clinical practice, it is quite common to diagnose a lesion in the bone or soft tissues that is amenable to biopsy. This is particularly true in patients who come to the hospital with a history of cancer, with radiological signs consistent with malignancy, or with the suspicion of focal septic inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Issakov J, Flusser G, Kollender Y, Merimsky O, Lifschitz-Mercer B, Meller I. Computed tomography-guided core needle biopsy for bone and soft tissue tumors. Isr Med Assoc J. 2003;5(1):28–30.

    PubMed  Google Scholar 

  2. Kiatisevi P, Thanakit V, Sukunthanak B, Boonthatip M, Bumrungchart S, Witoonchart K. Computed tomography-guided core needle biopsy versus incisional biopsy in diagnosing musculoskeletal lesions. J Orthop Surg (Hong Kong). 2013;21(2):204–8.

    Google Scholar 

  3. Koscick RL, Petersilge CA, Makley JT, Abdul-Karim FW. CT-guided fine needle aspiration and needle core biopsy of skeletal lesions. Complementary diagnostic techniques. Acta Cytol. 1998;42(3):697–702.

    Article  CAS  PubMed  Google Scholar 

  4. Jelinek JS, Murphey MD, Welker JA, Henshaw RM, Kransdorf MJ, Shmookler BM, et al. Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors. Radiology. 2002;223(3):731–7.

    Article  PubMed  Google Scholar 

  5. Holzapfel BM, Ludemann M, Holzapfel DE, Rechl H, Rudert M. Open biopsy of bone and soft tissue tumors: guidelines for precise surgical procedures. Oper Orthop Traumatol. 2012;24(4–5):403–15; quiz 416–7.

    Google Scholar 

  6. Ferguson KB, McGlynn J, Jane M, Ritchie D, Mahendra A. Outcome of image-guided biopsies: retrospective review of the west of Scotland musculoskeletal oncology service. Surgeon. 2014. pii: S1479–666X(14)00119-X. doi: 10.1016/j.surge.2014.09.002. [Epub ahead of print].

    Google Scholar 

  7. Toomayan GA, Major NM. Utility of CT-guided biopsy of suspicious skeletal lesions in patients with known primary malignancies. AJR Am J Roentgenol. 2011;196(2):416–23.

    Article  PubMed  Google Scholar 

  8. Saghieh S, Masrouha KZ, Musallam KM, Mahfouz R, Abboud M, Khoury NJ, et al. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010;30:80–3.

    PubMed  PubMed Central  Google Scholar 

  9. Gasbarrini A, Boriani L, Salvadori C, Mobarec S, Kreshak J, Nanni C, et al. Biopsy for suspected spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012;16 Suppl 2:26–34.

    PubMed  Google Scholar 

  10. Gasbarrini A, Boriani L, Nanni C, Zamparini E, Rorato G, Ghermandi R, et al. Spinal infection multidisciplinary management project (SIMP): from diagnosis to treatment guideline. Int J Immunopathol Pharmacol. 2011;24(1 Suppl 2):95–100.

    CAS  PubMed  Google Scholar 

  11. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 Suppl 3:iii11–24.

    CAS  PubMed  Google Scholar 

  12. Toner GC, Hicks RJ. PET for sarcomas other than gastrointestinal stromal tumors. Oncologist. 2008;13 Suppl 2:22–6.

    Article  PubMed  Google Scholar 

  13. Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D, et al. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2009;15(8):2856–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Benz MR, Czernin J, Tap WD, Eckardt JJ, Seeger LL, Allen-Auerbach MS, et al. FDG-PET/CT imaging predicts histopathologic treatment responses after neoadjuvant therapy in adult primary bone sarcomas. Sarcoma. 2010;2010:143540.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD. Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol. 2009;21(4):345–51.

    Article  PubMed  Google Scholar 

  16. Borbely K, Nemeth Z, Kasler M. Clinical application of 18F-FDG PET/CT in the treatment of sarcomas. Magy Onkol. 2014;58(1):24–31.

    PubMed  Google Scholar 

  17. Ceyssens S, Stroobants S. Sarcoma. Methods Mol Biol (Clifton NJ). 2011;727:191–203.

    Article  Google Scholar 

  18. Charest M, Hickeson M, Lisbona R, Novales-Diaz J-A, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging. 2009;36(12):1944–51.

    Article  PubMed  Google Scholar 

  19. Costelloe CM, Raymond AK, Fitzgerald NE, Mawlawi OR, Nunez RF, Madewell JE, et al. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol. 2010;39(2):131–40.

    Article  PubMed  Google Scholar 

  20. Dimitrakopoulou-Strauss A, Strauss LG, Egerer G, Vasamiliette J, Schmitt T, Haberkorn U, et al. Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis. Eur J Nucl Med Mol Imaging. 2010;37(8):1481–9.

    Article  CAS  PubMed  Google Scholar 

  21. Eary JF, Hawkins DS, Rodler ET, Conrad 3rd EU. (18)F-FDG PET in sarcoma treatment response imaging. Am J Nucl Med Mol Imaging. 2011;1(1):47–53.

    PubMed  PubMed Central  Google Scholar 

  22. Ferrari S, Balladelli A, Palmerini E, Vanel D. Imaging in bone sarcomas. The chemotherapist’s point of view. Eur J Radiol. 2013;82(12):2076–82.

    Article  PubMed  Google Scholar 

  23. Herrmann K, Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, et al. 18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy. Clin Cancer Res. 2012;18(7):2024–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Im HJ, Kim TS, Park S-Y, Min HS, Kim JH, Kang HG, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39(1):39–49.

    Article  CAS  PubMed  Google Scholar 

  25. Kolesnikov-Gauthier H, Leblond P, Rocourt N, Carpentier P. Contribution of FDG-PET in the management of pediatric sarcomas in 2011. Bull Cancer (Paris). 2011;98(5):501–14.

    Google Scholar 

  26. Amini B, Madewell JE, Chuang HH, Haygood TM, Hobbs BP, Fox PS, et al. Differentiation of benign fluid collections from soft-tissue sarcomas on. J Cancer. 2014;5(5):328–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine, AOU Policlinico S.Orsola-Malpighi, Bologna, Italy

    Cristina Nanni, Elena Tabacchi & Stefano Fanti

Authors
  1. Cristina Nanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Tabacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefano Fanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Nanni .

Editor information

Editors and Affiliations

  1. PET/CT Center, Quanta Diagnóstico e Terapia, Curitiba, Paraná, Brazil

    Juliano Cerci

  2. Ospedale S. Orsola Malpighi, Universitary Hospital, Bologna, Italy

    Stefano Fanti

  3. Radiology&Radiological Sciences, Vanderbilt University Medical Cente, Nashville, Tennessee, USA

    Dominique Delbeke

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing

About this chapter

Cite this chapter

Nanni, C., Tabacchi, E., Fanti, S. (2016). 18F-FDG PET/CT for Bone and Soft Tissue Biopsy. In: Cerci, J., Fanti, S., Delbeke, D. (eds) Oncological PET/CT with Histological Confirmation. Springer, Cham. https://doi.org/10.1007/978-3-319-27880-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27880-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27878-0

  • Online ISBN: 978-3-319-27880-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation